About

Publications While At HealthPartners

selected publications

Journal Article

Orteronel for metastatic hormone-sensitive prostate cancer: a multicenter, randomized, open-label phase III trial (SWOG-1216). 

Journal of Clinical Oncology. 2022

A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer. 

Cancer Chemotherapy and Pharmacology. 2017

Contact

full name

P. N. Lara

Quick Info

 

Collaboration

Co-author network

Map of science